Use of Recombinant Human Serum Albumin in Pediatric Patients with Nephrotic Syndrome
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Kasahara A, Kita K, Tomita E, Toyota J, Imai Y, Kumada H
. Repeated administration of recombinant human serum albumin caused no serious allergic reactions in patients with liver cirrhosis: a multicenter clinical study. J Gastroenterol. 2008; 43(6):464-72.
DOI: 10.1007/s00535-008-2178-5.
View
2.
Matejtschuk P, Dash C, Gascoigne E
. Production of human albumin solution: a continually developing colloid. Br J Anaesth. 2001; 85(6):887-95.
DOI: 10.1093/bja/85.6.887.
View
3.
Ohnishi K, Kawaguchi A, Nakajima S, Mori H, Ueshima T
. A comparative pharmacokinetic study of recombinant human serum albumin with plasma-derived human serum albumin in patients with liver cirrhosis. J Clin Pharmacol. 2008; 48(2):203-8.
DOI: 10.1177/0091270007310549.
View
4.
Dharmaraj R, Hari P, Bagga A
. Randomized cross-over trial comparing albumin and frusemide infusions in nephrotic syndrome. Pediatr Nephrol. 2009; 24(4):775-82.
DOI: 10.1007/s00467-008-1062-0.
View
5.
Kobayashi K
. Summary of recombinant human serum albumin development. Biologicals. 2006; 34(1):55-9.
DOI: 10.1016/j.biologicals.2005.08.021.
View